The effects of manganese on glutamate, dopamine and γ-aminobutyric acid regulation

Neurochemistry International

Volumn 48, Issue 6-7, 2006, Pages 426-433

  Fitsanakis, Vanessa A ^a   Au, Catherine ^b   Erikson, Keith M ^c   Aschner, Michael ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

Author keywords

Basal ganglia; Dopamine; GABA; Glutamate; Manganese neurotoxicity

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; GLUTAMIC ACID; MANGANESE; NEUROTRANSMITTER;

4 AMINOBUTYRIC ACID METABOLISM; AMINO ACID METABOLISM; ARTICLE; BASAL GANGLION; BIOACCUMULATION; BRAIN LEVEL; DOPAMINE METABOLISM; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; EXCITOTOXICITY; EXPOSURE; GABAERGIC SYSTEM; GLOBUS PALLIDUS; HUMAN; MOLECULAR INTERACTION; NERVE DEGENERATION; NERVE PROJECTION; NEUROCHEMISTRY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; SUBSTANTIA NIGRA; SYMPTOM;

ANIMALS; BASAL GANGLIA; DOPAMINE; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; GLUTAMIC ACID; HUMANS; MANGANESE;

EID: 33645867691     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2005.10.012     Document Type: Article

References (80)

1. Ali M., Murthy R., Saxena D., and Chandra S. Effect of low protein diet on manganese neurotoxicity: II. Brain GABA and seizure susceptibility. Neurobehav. Toxicol. Teratol. 5 (1983) 385-389
2. Aschner M. Neuron-astrocyte interactions: implications for cellular energetics and antioxidant levels. Neurotoxicology 21 (2000) 1101-1107
3. Aschner M., Allen J.W., Kimelberg H.K., LoPachin R.M., and Streit W.J. Glial cells in neurotoxicity development. Annu. Rev. Pharmacol. Toxicol. 39 (1999) 151-173
4. Bertinet D.B., Tinivella M., Balzola F.A., de Francesco A., Davini O., Rizzo L., Massarenti P., Leonardi M.A., and Balzola F. Brain manganese deposition and blood levels in patients undergoing home parenteral nutrition. JPEN J. Parenter Enteral Nutr. 24 (2000) 223-227
5. Bhargava H. Effect of repeated administration of manganese on the striatal cholinergic and dopaminergic receptors in the rat. Toxicol. Lett. 37 (1987) 135-141
6. Bolte S., Normandin L., Kennedy G., and Zayed J. Human exposure to respirable manganese in outdoor and indoor air in urban and rural areas. J. Toxicol. Environ. Health A 67 (2004) 459-467
7. Bonilla E. Increased GABA content in caudate nucleus of rats after chronic manganese chloride administration. J. Neurochem. 31 (1978) 551-552
8. Calabresi P., Ammassari-Teule M., Gubellini P., Sancesario G., Morello M., Centonze D., Marfia G., Saulle E., Passino E., Picconi B., and Bernardi G. A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication. Neurobiol. Dis. 8 (2001) 419-432
9. Calne D.B., Chu N.S., Huang C.C., Lu C.S., and Olanow W. Manganism and idiopathic parkinsonism: similarities and differences. Neurology 44 (1994) 1583-1586
10. Cano G., Suarez-Roca H., and Bonilla E. Manganese poisoning reduces strychnine-insensitive glycine binding sites in the globus pallidus of the mouse brain. Invest. Clin. 37 (1996) 209-219
11. Castilho R.F., Ward M.W., and Nicholls D.G. Oxidative stress, mitochondrial function, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurochem. 72 (1999) 1394-1401
12. Centonze D., Gubellini P., Bernardi G., and Calabresi P. Impaired excitatory transmission in the striatum of rats chronically intoxicated with manganese. Exp. Neurol. 172 (2001) 469-476
13. Chandra S., Malhorta K., and Shukla G. GABAergic neurochemistry in manganese exposed rats. Acta Pharmacol. Toxicol. (Copenh.) 51 (1982) 456-458
14. Ciliax B., Heilman C., Dernchyshyn L., Pristupa Z., Ince E., Hersch S., Niznik H., and Levey A. The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15 (1995) 1714-1723
15. Cooper J., Bloom F., and Roth R. Amino acid transmitters. In: Cooper J., et al. (Ed). The Biochemical Basis of Neuropharmacology (1996), Oxford University Press, New York 126-193
16. Cooper J., Bloom F., and Roth R. Dopamine. In: Cooper J., et al. (Ed). The Neurochemical Basis on Neuropharmacology (1996), Oxford University Press, New York 293-351
17. Cotman C., Haycock J., and White W. Stimulus-secretion coupling processess in brain: analysis of noradrenaline and gamma-aminobutyric acid release. J. Physiol. 254 (1978) 475-505
18. Danbolt N.C. Glutamate uptake. Prog. Neurobiol. 65 (2001) 1-105
19. Defazio G., Soleo L., Zefferino R., and Livrea P. Manganese toxicity in serumless dissociated mesencephalic and striatal primary culture. Brain Res. Bull. 40 (1996) 257-262
20. Desole M.S., Sciola L., Delogu M.R., Sircana S., Migheli R., and Miele E. Role of oxidative stress in the manganese and 1-methyl-4-(2′-ethylphenyl)-1,2,3,6-tetrahydropyridine-induced apoptosis in PC12 cells. Neurochem. Int. 31 (1997) 169-176
21. Erikson K., John C., Jones S., and Aschner M. Manganese accumulation in striatum of mice exposed to toxic doses is dependent upon a functional dopamine transporter. Environ. Toxicol. Pharmacol. 20 (2005) 390-394
22. Erikson K., Shihabi Z., and Aschner M. Manganese accumulates in iron-deficient rat brain retions in a heterogeneous fashion and is associated with neurochemical alterations. Biol. Trace Elem. Res. 87 (2002) 143-156
23. Erikson K.M., and Aschner M. Manganese neurotoxicity and glutamate-GABA interaction. Neurochem. Int. 43 (2003) 475-480
24. Erikson K.M., Suber R.L., and Aschner M. Glutamate/aspartate transporter (GLAST), taurine transporter and metallothionein mRNA levels are differentially altered in astrocytes exposed to manganese chloride, manganese phosphate or manganese sulfate. Neurotoxicology 23 (2002) 281-288
25. Eriksson H., Gillberg P., Aquilonius S., Hedstrom K., and Heilbronn E. Receptor alterations in manganese intoxicated monkeys. Arch. Toxicol. 66 (1992) 359-364
26. Finley J.W. Manganese absorption and retention by young women is associated with serum ferritin concentration. Am. J. Clin. Nutr. 70 (1999) 37-43
27. Fishman B., McGinley P., and Gianutsos G. Neurotoxic effects of methylcyclopentadienyl manganese tricarbonyl (MMT) in the mouse: basis of MMT-induced seizure activity. Toxicology 45 (1987) 193-201
28. Fitsanakis V.A., and Aschner M. The importance of glutamate, glycine, and gamma-aminobutyric acid transport and regulation in manganese, mercury and lead neurotoxicity. Toxicol. Appl. Pharmacol. 204 (2005) 343-354
29. Fitzgerald K., Mikalunas V., Rubin H., McCarthey R., Vanagunas A., and Craig R.M. Hypermanganesemia in patients receiving total parenteral nutrition. JPEN J. Parenter Enteral Nutr. 23 (1999) 333-336
30. Garcia-Avila M., and Penalver-Ballina R. Manganese poisoning in the mines of Cuba. Ind. Med. Surg. 22 (1953) 220-221
31. Gavin C.E., Gunter K.K., and Gunter T.E. Manganese and calcium transport in mitochondria: implications for manganese toxicity. Neurotoxicology 20 (1999) 445-453
32. Gianutsos G., and Murray M. Alterations in brain dopamine and GABA following inorganic or organic manganese administration. Neurotoxicology 3 (1982) 75-81
33. Gwiazda R., Lee D., Sheridan J., and Smith D. Low cumulative manganese exposure affects striatal GABA but not DA. Neurotoxicology 23 (2002) 69-76
34. Hauser R.A., Zesiewicz T.A., Martinez C., Rosemurgy A.S., and Olanow C.W. Blood manganese correlates with brain magnetic resonance imaging changes in patients with liver disease. Can. J. Neurol. Sci. 23 (1996) 95-98
35. Hazell A.S. Astrocytes and manganese neurotoxicity. Neurochem. Int. 41 (2002) 271-277
36. Huang C., Wend Y., Lu C., Chu N., and Yen T. Dopamine transporter binding in chronic manganese intoxication. J. Neurol. 250 (2003) 1335-1339
37. Ingersoll R., Montgomery Jr. E., and Aposhian H. Central nervous system toxicity of manganese. II: cocaine or reserpine inhibit manganese concentration in the rat brain. Neurotoxicology 20 (1999) 467-476
38. Jaber M., Dumartin B., Sagne C., Haycock J., Roubert C., Giros B., Bloch B., and Caron M. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur. J. Neurosci. 11 (1999) 3499-3511
39. Kim Y., Park J.K., Choi Y., Yoo C.I., Lee C.R., Lee H., Lee J.H., Kim S.R., Jeong T.H., Yoon C.S., and Park J.H. Blood manganese concentration is elevated in iron deficiency anemia patients, whereas globus pallidus signal intensity is minimally affected. Neurotoxicology 26 (2005) 107-111
40. Levy B.S., and Nassetta W.J. Neurologic effects of manganese in humans: a review. Int. J. Occup. Environ. Health 9 (2003) 153-163
41. Lipe G., Duhart H., Newport G., Slikker Jr. W., and Ali S. Effect of manganese on the concentration of amino acids in different regions of the rat brain. J. Environ. Sci. Health B 34 (1999) 119-132
42. Mash D., and Staley J. The dopamine transporter in human brain. In: Reith M. (Ed). Neurotranmitter Transporters: Structure, Function and Regulation (1997), Humana Press, Totowa, NJ 315-343
43. Miele M., Serra P.A., Esposito G., Delogu M.R., Migheli R., Rocchitta G., and Desole M.S. Glutamate and catabolites of high-energy phosphates in the striatum and brainstem of young and aged rats subchronically exposed to manganese. Aging (Milano) 12 (2000) 393-397
44. Miller J., Kleven D., Domin B., and Fremeau Jr. A. Cloned sodium- (and chloride-) dependent high-affinity transporters for GABA, glycine, proline, betaine, taurine and creatine. In: Reith M. (Ed). Neurotransmitter Transporters: Structure, Function, and Regulation (1997), Humana Press, Totowa, NJ 109-149
45. Montes S., Alcaraz-Zubeldia M., Muriel P., and Rios C. Striatal manganese accumulation induces changes in dopamine metabolism in the cirrhotic rat. Brain Res. 891 (2001) 123-129
46. Montes S., Alcaraz-Zubeldia M., Muriel P., and Rios C. Role of manganese accumulation in increased brain glutamine of the cirrhotic rat. Neurochem. Res. 28 (2003) 911-917
47. Myers J.E., teWaterNaude J., Fourie M., Zogoe H.B., Naik I., Theodorou P., Tassel H., Daya A., and Thompson M.L. Nervous system effects of occupational manganese exposure on South African manganese mineworkers. Neurotoxicology 24 (2003) 649-656
48. Neve K., and Neve R. The Dopamine Receptors (1997), Humana Press, Totowa, NJ
49. Normandin L., and Hazell A.S. Manganese neurotoxicity: an update of pathophysiologic mechanisms. Metab. Brain Dis. 17 (2002) 375-387
50. Obeso J.A., Rodriguez-Oroz M.C., Rodriguez M., Arbizu J., and Gimenez-Amaya J.M. The basal ganglia and disorders of movement: pathophysiological mechanisms. News Physiol. Sci. 17 (2002) 51-55
51. Pal P., Samii A., and Calne D. Manganese neurotoxicity: a review of clinical features, imaging and pathology. Neurotoxicology 20 (1999) 227-238
52. Pfeifer G.D., Roper J.M., Dorman D., and Lynam D.R. Health and environmental testing of manganese exhaust products from use of methylcyclopentadienyl manganese tricarbonyl in gasoline. Sci. Total Environ. 334-335 (2004) 397-408
53. Racette B.A., Antenor J.A., McGee-Minnich L., Moerlein S.M., Videen T.O., Kotagal V., and Perlmutter J.S. [18F]FDOPA PET and clinical features in parkinsonism due to manganism. Mov. Disord. 20 (2005) 492-496
54. Racette B.A., McGee-Minnich L., Moerlein S.M., Mink J.W., Videen T.O., and Perlmutter J.S. Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 56 (2001) 8-13
55. Ressler T., Wong J., and Roos J. Manganese speciation in exhaust particulates of automobiles using MMT-containing gasoline. J. Synchrotron Radiat. 6 (1999) 656-658
56. Ritz M., Cone E., and Kuhar M. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci. 46 (1990) 635-645
57. Ritz M., Lamb R., Goldberg S., and Kuhar M. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237 (1987) 1219-1223
58. Rodier J. Manganese poisoning in Moroccan miners. Br. J. Ind. Med. 12 (1955) 21-35
59. Rollin H., Mathee A., Levin J., Theodorou P., and Wewers F. Blood manganese concentrations among first-grade schoolchildren in two South African cities. Environ. Res. 97 (2005) 93-99
60. Rose C., Butterworth R.F., Zayed J., Normandin L., Todd K., Michalak A., Spahr L., Huet P.M., and Pomier-Layrargues G. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117 (1999) 640-644
61. Sadek A.H., Rauch R., and Schulz P.E. Parkinsonism due to manganism in a welder. Int. J. Toxicol. 22 (2003) 393-401
62. Seth P., and Chandra S. Neurotransmiters and neurotransmitter receptors in developing and adult rats during manganese poisoning. Neurotoxicology 5 (1984) 67-76
63. Seth P., Hong J., Kits C., and Bondy S. Alteration of cerebral neurotransmitter receptor function by exposure of rats to manganese. Toxicol. Lett. 9 (1981) 247-254
64. Sibley D., Monsma F., and Shen Y. Molecular neurobiology of dopaminergic receptors. Int. Rev. Neurobiol. 35 (1993) 391-415
65. Slemmer J.E., De Zeeuw C.I., and Weber J.T. Don't get too excited: mechanisms of glutamate-mediated Purkinje cell death. Prog. Brain Res. 148 (2005) 367-390
66. Snyder S., and D'Amato R. MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. Neurology 36 (1986) 250-258
67. Spadoni F., Stefani A., Morello M., Lavaroni F., Giacomini P., and Sancesario G. Selective vulnerability of pallidal neurons in the early phases of manganese intoxication. Exp. Brain Res. 135 (2000) 544-551
68. Stokes A.H., Lewis D.Y., Lash L.H., Jerome III W.G., Grant K.W., Aschner M., and Vrana K.E. Dopamine toxicity in neuroblastoma cells: role of glutathione depletion by L-BSO and apoptosis. Brain Res. 858 (2000) 1-8
69. Takagi Y., Okada A., Sando K., Wasa M., Yoshida H., and Hirabuki N. On-off study of manganese administration to adult patients undergoing home parenteral nutrition: new indices of in vivo manganese level. JPEN J. Parenter Enteral Nutr. 25 (2001) 87-92
70. Takeda A. Manganese action in brain function. Brain Res. Brain Res. Rev. 41 (2003) 79-87
71. Takeda A., Sotogaku N., and Oku N. Manganese influences the levels of neurotransmitters in synapses in rat brain. Neuroscience 114 (2002) 669-674
72. Takeda A., Sotogaku N., and Oku N. Influence of manganese on the release of neurotransmitters in rat striatum. Brain Res. 965 (2003) 279-282
73. Tarazi F., Tomasini E., and Baldessarini R. Postnatal development of dopamine and serotonin transporters in rat caudate putamen and nucleus accumbens septi. Neurosci. Lett. 254 (1998) 21-24
74. Tomas-Camardiel M., Herrera A., Venero J., Sanchez-Hidalgo M., Cano J., and Machado A. Differential regulation of glutamic acid decarboxylase mRNA and tyrosine hydroxylase mRNA in aged manganese-treated rats. Brain Res. Mol. Brain Res. 103 (2002) 116-129
75. Torrey E., Barci B., Webster M., Bartko J., Meador-Woodruff J., and Knable M. Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains. Biol. Psychiatry 57 (2005) 252-260
76. Tran T., Chowanadisai W., Crinella F., Chicz-DeMet A., and Lonnerdal B. Effect of high dietary manganese intake of neonatal rats on tissue mineral accumulation, striatal dopamine levels, and neurodevelopmental status. Neurotoxicology 23 (2002) 635-643
77. Vallone D., Picetti R., and Borrelli E. Structure and function of dopamine receptors. Neurol. Biobehav. Rev. 24 (2000) 125-132
78. Wong P., Lai J., Lim L., and Davidson A. Selective inhibition of l-glutamate and gammaaminobutyrate transport in nerve ending particles by aluminium, manganese, and cadmium chloride. J. Inorg. Biochem. 14 (1981) 256-260
79. Zwingmann C., Leibfritz D., and Hazell A.S. Energy metabolism in astrocytes and neurons treated with manganese: relation among cell-specific energy failure, glucose metabolism, and intercellular trafficking using multinuclear NMR-spectroscopic analysis. J. Cereb. Blood Flow Metab. 23 (2003) 756-771
80. Zwingmann C., Leibfritz D., and Hazell A.S. Brain energy metabolism in a sub-acute rat model of manganese neurotoxicity: an ex vivo nuclear magnetic resonance study using [1-13C]glucose. Neurotoxicology 25 (2004) 573-587